Credit Suisse’s Kymera Therapeutics KYMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $9.15M | Buy |
227,586
+63,434
| +39% | +$2.55M | 0.01% | 950 |
|
|
2023
Q4 | $4.18M | Buy |
164,152
+126,822
| +340% | +$3.23M | ﹤0.01% | 1428 |
|
|
2023
Q3 | $519K | Sell |
37,330
-10,149
| -21% | -$141K | ﹤0.01% | 2662 |
|
|
2023
Q2 | $1.09M | Buy |
47,479
+12,148
| +34% | +$279K | ﹤0.01% | 2317 |
|
|
2023
Q1 | $1.05M | Buy |
35,331
+3,066
| +10% | +$90.8K | ﹤0.01% | 2284 |
|
|
2022
Q4 | $805K | Buy |
32,265
+657
| +2% | +$16.4K | ﹤0.01% | 2472 |
|
|
2022
Q3 | $689K | Buy |
31,608
+8,364
| +36% | +$182K | ﹤0.01% | 2571 |
|
|
2022
Q2 | $457K | Sell |
23,244
-61
| -0.3% | -$1.2K | ﹤0.01% | 2882 |
|
|
2022
Q1 | $987K | Buy |
23,305
+3,735
| +19% | +$158K | ﹤0.01% | 2544 |
|
|
2021
Q4 | $1.24M | Buy |
19,570
+2,973
| +18% | +$189K | ﹤0.01% | 2443 |
|
|
2021
Q3 | $975K | Buy |
16,597
+9,906
| +148% | +$582K | ﹤0.01% | 2602 |
|
|
2021
Q2 | $324K | Sell |
6,691
-3,093
| -32% | -$150K | ﹤0.01% | 3250 |
|
|
2021
Q1 | $380K | Sell |
9,784
-1,133
| -10% | -$44K | ﹤0.01% | 3077 |
|
|
2020
Q4 | $677K | Buy |
+10,917
| New | +$677K | ﹤0.01% | 2816 |
|